• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表达真实的人类 VRC01 类 BCR 的 B 细胞可以在多个独立的小鼠模型中被招募到生发中心并进行亲和力成熟。

B cells expressing authentic naive human VRC01-class BCRs can be recruited to germinal centers and affinity mature in multiple independent mouse models.

机构信息

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037.

Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA 92037.

出版信息

Proc Natl Acad Sci U S A. 2020 Sep 15;117(37):22920-22931. doi: 10.1073/pnas.2004489117. Epub 2020 Sep 1.

DOI:10.1073/pnas.2004489117
PMID:32873644
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7502816/
Abstract

Animal models of human antigen-specific B cell receptors (BCRs) generally depend on "inferred germline" sequences, and thus their relationship to authentic naive human B cell BCR sequences and affinities is unclear. Here, BCR sequences from authentic naive human VRC01-class B cells from healthy human donors were selected for the generation of three BCR knockin mice. The BCRs span the physiological range of affinities found in humans, and use three different light chains (VK3-20, VK1-5, and VK1-33) found among subclasses of naive human VRC01-class B cells and HIV broadly neutralizing antibodies (bnAbs). The germline-targeting HIV immunogen eOD-GT8 60mer is currently in clinical trial as a candidate bnAb vaccine priming immunogen. To attempt to model human immune responses to the eOD-GT8 60mer, we tested each authentic naive human VRC01-class BCR mouse model under rare human physiological B cell precursor frequency conditions. B cells with high (HuGL18) or medium (HuGL17) affinity BCRs were primed, recruited to germinal centers, and they affinity matured, and formed memory B cells. Precursor frequency and affinity interdependently influenced responses. Taken together, these experiments utilizing authentic naive human VRC01-class BCRs validate a central tenet of germline-targeting vaccine design and extend the overall concept of the reverse vaccinology approach to vaccine development.

摘要

人体抗原特异性 B 细胞受体 (BCR) 的动物模型通常依赖于“推断的种系”序列,因此它们与真实的人类初始 B 细胞 BCR 序列和亲和力的关系尚不清楚。在这里,从健康供体的真实初始人类 VRC01 类 B 细胞中选择了 BCR 序列,用于生成三只 BCR 敲入小鼠。这些 BCR 跨越了人类中发现的生理亲和力范围,并使用了三种不同的轻链(VK3-20、VK1-5 和 VK1-33),这些轻链存在于初始人类 VRC01 类 B 细胞和 HIV 广谱中和抗体 (bnAb) 的亚类中。目前,种系靶向 HIV 免疫原 eOD-GT8 60mer 正在作为候选 bnAb 疫苗初始免疫原进行临床试验。为了尝试模拟人类对 eOD-GT8 60mer 的免疫反应,我们在罕见的人类生理 B 细胞前体频率条件下测试了每种真实初始人类 VRC01 类 BCR 小鼠模型。具有高 (HuGL18) 或中 (HuGL17) 亲和力 BCR 的 B 细胞被初始化、募集到生发中心,并进行亲和力成熟,形成记忆 B 细胞。前体频率和亲和力相互影响反应。总之,这些利用真实初始人类 VRC01 类 BCR 的实验验证了种系靶向疫苗设计的一个基本原则,并扩展了反向疫苗学方法在疫苗开发中的总体概念。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb12/7502816/bc37b39046e6/pnas.2004489117fig07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb12/7502816/605058b1f823/pnas.2004489117fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb12/7502816/da8126448c06/pnas.2004489117fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb12/7502816/20fc8dbd0700/pnas.2004489117fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb12/7502816/a2e29e7dd49d/pnas.2004489117fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb12/7502816/38cdf53116ac/pnas.2004489117fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb12/7502816/f06be80ff239/pnas.2004489117fig06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb12/7502816/bc37b39046e6/pnas.2004489117fig07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb12/7502816/605058b1f823/pnas.2004489117fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb12/7502816/da8126448c06/pnas.2004489117fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb12/7502816/20fc8dbd0700/pnas.2004489117fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb12/7502816/a2e29e7dd49d/pnas.2004489117fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb12/7502816/38cdf53116ac/pnas.2004489117fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb12/7502816/f06be80ff239/pnas.2004489117fig06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb12/7502816/bc37b39046e6/pnas.2004489117fig07.jpg

相似文献

1
B cells expressing authentic naive human VRC01-class BCRs can be recruited to germinal centers and affinity mature in multiple independent mouse models.表达真实的人类 VRC01 类 BCR 的 B 细胞可以在多个独立的小鼠模型中被招募到生发中心并进行亲和力成熟。
Proc Natl Acad Sci U S A. 2020 Sep 15;117(37):22920-22931. doi: 10.1073/pnas.2004489117. Epub 2020 Sep 1.
2
The human naive B cell repertoire contains distinct subclasses for a germline-targeting HIV-1 vaccine immunogen.人类幼稚 B 细胞库中含有针对 HIV-1 疫苗免疫原的独特种系靶向亚类。
Sci Transl Med. 2018 Jul 4;10(448). doi: 10.1126/scitranslmed.aat0381.
3
HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen.通过靶向胚系免疫原揭示的HIV-1广泛中和抗体前体B细胞
Science. 2016 Mar 25;351(6280):1458-63. doi: 10.1126/science.aad9195.
4
Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies.聚糖掩蔽作用聚焦于 HIV-1 的 CD4 结合位点的免疫反应,并增强了 VRC01 类前体抗体的产生。
Immunity. 2018 Aug 21;49(2):301-311.e5. doi: 10.1016/j.immuni.2018.07.005. Epub 2018 Jul 31.
5
HIV-1 VRC01 Germline-Targeting Immunogens Select Distinct Epitope-Specific B Cell Receptors.HIV-1 VRC01 种系靶向免疫原选择不同的表位特异性 B 细胞受体。
Immunity. 2020 Oct 13;53(4):840-851.e6. doi: 10.1016/j.immuni.2020.09.007.
6
Precursor Frequency and Affinity Determine B Cell Competitive Fitness in Germinal Centers, Tested with Germline-Targeting HIV Vaccine Immunogens.前体细胞频率和亲和力决定生发中心 B 细胞的竞争适应性,用针对 HIV 疫苗免疫原的种系靶向方法进行测试。
Immunity. 2018 Jan 16;48(1):133-146.e6. doi: 10.1016/j.immuni.2017.11.023. Epub 2017 Dec 26.
7
mRNA-LNP prime boost evolves precursors toward VRC01-like broadly neutralizing antibodies in preclinical humanized mouse models.mRNA-LNP 初免-加强诱导前体向 VRC01 样广泛中和抗体进化,在临床前人源化小鼠模型中。
Sci Immunol. 2024 May 10;9(95):eadn0622. doi: 10.1126/sciimmunol.adn0622. Epub 2024 May 16.
8
Priming HIV-1 broadly neutralizing antibody precursors in human Ig loci transgenic mice.在人免疫球蛋白基因座转基因小鼠中启动HIV-1广泛中和抗体前体。
Science. 2016 Sep 30;353(6307):1557-1560. doi: 10.1126/science.aah3945. Epub 2016 Sep 8.
9
Humanized V(D)J-rearranging and TdT-expressing mouse vaccine models with physiological HIV-1 broadly neutralizing antibody precursors.具有生理 HIV-1 广泛中和抗体前体的人源化 V(D)J 重排和 TdT 表达的小鼠疫苗模型。
Proc Natl Acad Sci U S A. 2023 Jan 3;120(1):e2217883120. doi: 10.1073/pnas.2217883120. Epub 2022 Dec 27.
10
Multiplexed CRISPR/CAS9-mediated engineering of pre-clinical mouse models bearing native human B cell receptors.多重 CRISPR/CAS9 介导的工程化修饰携带天然人 B 细胞受体的临床前小鼠模型。
EMBO J. 2021 Jan 15;40(2):e105926. doi: 10.15252/embj.2020105926. Epub 2020 Dec 1.

引用本文的文献

1
Structural insights into VRC01-class bnAb precursors with diverse light chains elicited in the IAVI G001 human vaccine trial.在IAVI G001人体疫苗试验中引发的具有不同轻链的VRC01类广谱中和抗体前体的结构见解。
Proc Natl Acad Sci U S A. 2025 Aug 19;122(33):e2510163122. doi: 10.1073/pnas.2510163122. Epub 2025 Aug 11.
2
Priming VRC01-precursor B cells with non-envelope immunogens disfavors boosting with HIV-1 envelope.用非包膜免疫原启动VRC01前体B细胞不利于用HIV-1包膜进行增强免疫。
NPJ Vaccines. 2025 Aug 5;10(1):185. doi: 10.1038/s41541-025-01235-5.
3
Rapid acquisition of HIV-1 neutralization breadth in a rhesus V2 apex germline antibody mouse model after a single bolus immunization.

本文引用的文献

1
Targeted selection of HIV-specific antibody mutations by engineering B cell maturation.通过工程化 B 细胞成熟来靶向选择 HIV 特异性抗体突变。
Science. 2019 Dec 6;366(6470). doi: 10.1126/science.aay7199.
2
Overcoming Steric Restrictions of VRC01 HIV-1 Neutralizing Antibodies through Immunization.通过免疫克服 VRC01 HIV-1 中和抗体的空间位阻。
Cell Rep. 2019 Dec 3;29(10):3060-3072.e7. doi: 10.1016/j.celrep.2019.10.071.
3
Immunization: vital progress, unfinished agenda.免疫接种:至关重要的进展,尚未完成的议程。
在恒河猴V2尖峰种系抗体小鼠模型中,单次大剂量免疫后HIV-1中和广度的快速获得。
bioRxiv. 2025 Jun 17:2025.06.12.659380. doi: 10.1101/2025.06.12.659380.
4
Structural insights into VRC01-class bnAb precursors with diverse light chains elicited in the IAVI G001 human vaccine trial.在IAVI G001人体疫苗试验中引发的具有不同轻链的VRC01类广谱中和抗体前体的结构见解。
bioRxiv. 2025 May 27:2025.05.22.655646. doi: 10.1101/2025.05.22.655646.
5
Precise targeting of HIV broadly neutralizing antibody precursors in humans.在人类中对HIV广泛中和抗体前体进行精确靶向。
Science. 2025 Jul 31;389(6759):eadv5572. doi: 10.1126/science.adv5572.
6
Diverse priming outcomes under conditions of very rare precursor B cells.在极罕见的前体B细胞条件下的多种启动结果。
Immunity. 2025 Apr 8;58(4):997-1014.e11. doi: 10.1016/j.immuni.2025.03.003. Epub 2025 Mar 31.
7
Blunting specific T-dependent antibody responses with engineered "decoy" B cells.利用工程化“诱饵”B 细胞来钝化特定的 T 依赖性抗体反应。
Mol Ther. 2024 Oct 2;32(10):3453-3469. doi: 10.1016/j.ymthe.2024.08.023. Epub 2024 Aug 26.
8
Use of Transient Transfection for cGMP Manufacturing of eOD-GT8 60mer, a Self-Assembling Nanoparticle Germline-Targeting HIV-1 Vaccine Candidate.瞬时转染用于cGMP生产eOD-GT8 60聚体,一种自组装纳米颗粒靶向生殖系的HIV-1疫苗候选物。
Pharmaceutics. 2024 May 30;16(6):742. doi: 10.3390/pharmaceutics16060742.
9
Affinity gaps among B cells in germinal centers drive the selection of MPER precursors.生发中心 B 细胞之间的亲和力差距驱动 MPER 前体的选择。
Nat Immunol. 2024 Jun;25(6):1083-1096. doi: 10.1038/s41590-024-01844-7. Epub 2024 May 30.
10
Vaccination induces broadly neutralizing antibody precursors to HIV gp41.接种疫苗可诱导针对 HIV gp41 的广谱中和抗体前体。
Nat Immunol. 2024 Jun;25(6):1073-1082. doi: 10.1038/s41590-024-01833-w. Epub 2024 May 30.
Nature. 2019 Nov;575(7781):119-129. doi: 10.1038/s41586-019-1656-7. Epub 2019 Nov 6.
4
A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses.一种用于诱导广泛中和抗体反应的通用 HIV 疫苗设计策略。
Science. 2019 Dec 6;366(6470). doi: 10.1126/science.aax4380. Epub 2019 Oct 31.
5
Germline-Encoded Affinity for Cognate Antigen Enables Vaccine Amplification of a Human Broadly Neutralizing Response against Influenza Virus.胚系编码的对同源抗原的亲和力使针对流感病毒的人类广泛中和反应的疫苗得到扩增。
Immunity. 2019 Oct 15;51(4):735-749.e8. doi: 10.1016/j.immuni.2019.09.001. Epub 2019 Sep 25.
6
Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies.基于中和作用的设计,产生了对 CH235 谱系 CD4bs 广谱中和抗体的未突变共同祖先具有高亲和力的 HIV-1 包膜三聚体。
PLoS Pathog. 2019 Sep 17;15(9):e1008026. doi: 10.1371/journal.ppat.1008026. eCollection 2019 Sep.
7
Rapid and Focused Maturation of a VRC01-Class HIV Broadly Neutralizing Antibody Lineage Involves Both Binding and Accommodation of the N276-Glycan.N276-糖基的结合和构象变化促进 VRC01 类 HIV 广谱中和抗体谱系的快速和特异性成熟
Immunity. 2019 Jul 16;51(1):141-154.e6. doi: 10.1016/j.immuni.2019.06.004.
8
Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques.免疫接种可在小鼠和猕猴中扩增针对 HIV-1 V3 聚糖的 B 细胞特异性。
Nature. 2019 Jun;570(7762):468-473. doi: 10.1038/s41586-019-1250-z. Epub 2019 May 29.
9
T Follicular Helper Cell Biology: A Decade of Discovery and Diseases.滤泡辅助性 T 细胞生物学:十年的发现与疾病
Immunity. 2019 May 21;50(5):1132-1148. doi: 10.1016/j.immuni.2019.04.011.
10
B Cell Responses: Cell Interaction Dynamics and Decisions.B 细胞反应:细胞相互作用动力学与决策。
Cell. 2019 Apr 18;177(3):524-540. doi: 10.1016/j.cell.2019.03.016.